First Trust NYSE Arca Biotechnology Index Fund
255 hedge funds and large institutions have $746M invested in First Trust NYSE Arca Biotechnology Index Fund in 2023 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 53 increasing their positions, 98 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
46% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 98
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
255
Holding in Top 10
–
Calls
$948K
Puts
–
Top Buyers
| 1 | +$120M | |
| 2 | +$7.47M | |
| 3 | +$4.47M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$2.11M |
| 5 |
Jane Street
New York
|
+$1.9M |
Top Sellers
| 1 | -$67.6M | |
| 2 | -$9.42M | |
| 3 | -$8.07M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.18M |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$5.26M |